The inhaled bronchodilator continues to be the mainstay for asthma treatment. This despite the designation of asthma as an inflammatory disease and research findings that support maintenance treatment using corticosteroid medications.
Too often the quick fix of an inhaled bronchodilator wins out over the longer-term advantages of using a steroid. But bronchodilators can provide a false sense of security. Studies show that patients who rely on their bronchodilators are more likely to p